In-vitro capabilities

Pharmaseed’s in vitro capabilities provide support for all animal studies (i.e., cell culture, FACS, rtPCR, ELISA and more).
Our iv-vitro capabilities allow us to conduct trials which range from simple Cytotoxicity assays and Mixed cells cultures, up to more complex studies, including CART generation or stem cells differentiation.

Capabilities

Screening: +100 Human & Mouse Cell Lines

Molecular Biology – PCR, ELISA, ELISPOT & Multiplex

Mixed Lymphocyte Reaction (MLR) – Graft Vs. Host Disease

Primary Cell Cultures

Cell Viability Assays – MTT, XTT, BrdU, CellTiter-Gl

FACS

Molecular Pathology & IHC

Single Cell Suspension – GentleMacs

Cell Separation Techniques – Including Magnetic

Mixed Lymphocyte Tumor Reaction (MLTR)

Toll-like Receptor Studies

Cytokine Storm: Acute Respiratory Distress Syndrome (ARDS)

Angiogenesis

Cell Types

Advanced Capabilities

Stem Cell Differentiation
Viral Infections
CRISPR
3D Cultures
Macrophages
CAR-T